LePure Biotech reposted this
The pharmaceutical industry is staring down a major patent cliff, with more than $300B in sales at risk in coming years. Unlike the previous patent cliff, this one includes a fair number of biologics, making the transition to biosimilars highly relevant. Navigating this coming cliff will require a combination of innovation and strategy from the pharmaceutical industry and its supply chain.
Scientist and Engineer | Executive MBA | Pharma and Biotech Market Research | Science Liaison | Technical Writer | Medical Communications
💸 𝐖𝐡𝐢𝐜𝐡 𝐝𝐫𝐮𝐠𝐬 𝐰𝐢𝐥𝐥 𝐥𝐨𝐬𝐞 𝐩𝐚𝐭𝐞𝐧𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐦𝐢𝐧𝐠 𝐲𝐞𝐚𝐫𝐬? ⚆ Nearly 200 drugs are going off-patent in the near future ⚆ These include at least 69 blockbusters (>$1B in annual sales) ⚆ This could lead to over 49% revenue decline for major companies The pharmaceutical industry is staring down a major patent cliff, with more than $300B in sales at risk in coming years. Unlike the previous patent cliff, this one includes a fair number of biologics, making the transition to biosimilars highly relevant. Navigating this coming cliff will require a combination of innovation and strategy from the pharmaceutical industry. 𝘞𝘩𝘰 𝘸𝘪𝘭𝘭 𝘣𝘦 𝘵𝘩𝘦 𝘣𝘪𝘨𝘨𝘦𝘴𝘵 𝘭𝘰𝘴𝘦𝘳 𝘪𝘯 𝘵𝘩𝘦 𝘤𝘰𝘮𝘪𝘯𝘨 𝘺𝘦𝘢𝘳𝘴? Check the graphic and comment. *The infographic represents US patent expiry and is not exhaustive of all off-patents. #pharma #biotech #drjojo Sources: PharmaVoice, BioSpace, Statista